Gu-oc, Grace M.

HRN: 27-76-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
CEFUROXIME 500MG (TAB)
09/09/2025
09/15/2025
ORAL
500mg
Q12
PROM; Thinly MSAF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines